Brief: Spectral Medical Announces The Opening Of Two Additional Tigris Clinical Trial Sites
09/03/2023 13:15
March 9 (Reuters) - Spectral Medical Inc EDT.TO :
* SPECTRAL MEDICAL ANNOUNCES THE OPENING OF TWO ADDITIONAL
TIGRIS
CLINICAL TRIAL SITES
* SPECTRAL MEDICAL- ANNOUNCED OPENING OF 2 CLINICAL TRIALS
SITES
BRINGING TOTAL NUMBER OF ACTIVE CLINICAL TRIAL SITES TO 16 FOR
COMPANY'S TIGRIS TRIAL
Source text for Eikon: ID:nGNX9z33N3
Further company coverage: EDT.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectral Medical
See all newsBrief: Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting For PMX PMA
Canada's Spectral Medical Q2 revenue falls on lower reagent sales
Brief: Spectral Medical And Vantive Announce Topline 12 Month Follow-Up Results From Spectral’S Tigris Trial
Canada's Spectral Medical Q1 revenue rises 56%, net loss narrows
Spectral Medical Q3 revenue up 34%